The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors A Positron Emission Tomography Study With [11C]-(+)-PHNO

被引:82
作者
Graff-Guerrero, Ariel [2 ,3 ,4 ]
Mamo, David [2 ,3 ]
Shammi, C. M. [2 ,3 ]
Mizrahi, Romina [2 ,3 ]
Marcon, Heidi [3 ]
Barsoum, Penny [3 ]
Rusjan, Pablo [3 ]
Houle, Sylvain [2 ,3 ]
Wilson, Alan A. [2 ,3 ]
Kapur, Shitij [1 ,2 ,3 ]
机构
[1] Kings Coll London, Inst Psychiat, Div Psychol Med & Psychiat, London SE5 8AF, England
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
[3] Ctr Addict & Mental Hlth, Positron Emission Tomog Ctr, Toronto, ON, Canada
[4] Univ Nacl Autonoma Mexico, Inst Neurobiol, Mexico City 04510, DF, Mexico
关键词
STRIATAL DOPAMINE RELEASE; RAT-BRAIN; CLINICAL-RESPONSE; BINDING; AGONIST; PET; SCHIZOPHRENIA; OCCUPANCY; RADIOTRACER; PRAMIPEXOLE;
D O I
10.1001/archgenpsychiatry.2009.43
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: Most antipsychotics are thought to have an effect on D-2 and D-3 receptors. The development of carbon 11-labeled (+)-4-propyl-9-hydroxynaphthoxazine ([C-11]-(+)-PHNO), the first agonist radioligand with higher affinity for D-3 than D-2 receptors, allows one to differentiate the effects of antipsychotics on high-affinity vs low-affinity sites of the D-2 receptor and on D-3 vs D-2 receptor subtypes. Objectives: To examine the effects of antipsychotics (clozapine, risperidone, or olanzapine) on the high-vs high-+low-affinity sites of the D-2 and D-3 receptors by comparing the [C-11]-(+)-PHNO and [C-11]raclopride binding in the D-3 receptor-rich (globus pallidus and ventral striatum) and D-2 receptor-rich (caudate and putamen) regions. Design: Two sequential studies with different participants and appropriate controls were performed. The first compared the occupancy produced by 3 antipsychotics as measured with [C-11]-(+)-PHNO and [C-11]raclopride. The second was a double-blind, placebo-controlled experiment to compare the effect of pramipexole (a D-3 receptor-preferring agonist) vs placebo on the increased [C-11]-(+)-PHNO signal observed in the globus pallidus of patients. Setting: Positron Emission Tomography Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Participants: Twenty-three patients with schizophrenia and 23 healthy controls. Main Outcome Measures: Antipsychotic occupancies as measured with [C-11]-(+)-PHNO and [C-11]raclopride. Results: The antipsychotic-treated patients showed high occupancies with both [C-11]-(+)-PHNO and [C-11]raclopride in the dorsal striatum, with [C-11]raclopride occupancies about 20% higher. Most strikingly, patients did not show any occupancy with [C-11]-(+)-PHNO in the globus pallidus as compared with normal controls or with their own scans using [C-11]raclopride. This unblocked [C-11]-(+)-PHNO signal was displaced by a single dose of pramipexole. Conclusions: Antipsychotics block both the high-and low-affinity states of the D-2 receptors across the brain, but antipsychotic treatment does not block the [C-11](+)-PHNO signal in the D-3 receptor-rich regions, despite the ongoing D-2 receptor blockade. This [C-11]-(+)PHNO signal in regions such as the globus pallidus seems increased despite antipsychotic treatment and is displaceable by a D-3 receptor-preferring agonist. The radiotracer [C-11]-(+)-PHNO and the data open up new avenues for exploring the potential therapeutic significance of the D-3 receptor in schizophrenia.
引用
收藏
页码:606 / +
页数:12
相关论文
共 69 条
[41]   DOPAMINE D2 RECEPTORS MAPPED IN RAT-BRAIN WITH [H-3] (+)PHNO [J].
NOBREGA, JN ;
SEEMAN, P .
SYNAPSE, 1994, 17 (03) :167-172
[42]   Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients [J].
Nordström, AL ;
Nyberg, S ;
Olsson, H ;
Farde, L .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (03) :283-284
[43]   NO ELEVATED D-2 DOPAMINE-RECEPTORS IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS REVEALED BY POSITRON EMISSION TOMOGRAPHY AND [C-11] N-METHYLSPIPERONE [J].
NORDSTROM, AL ;
FARDE, L ;
ERIKSSON, L ;
HALLDIN, C .
PSYCHIATRY RESEARCH-NEUROIMAGING, 1995, 61 (02) :67-83
[44]   In vitro characterisation of the high affinity D2/D3 dopamine agonist (+)PhNO [J].
Parker, Christine ;
Clarke, K. ;
Gee, A. D. ;
Gee, A. ;
Rabiner, E. .
NEUROIMAGE, 2006, 31 :T29-T29
[45]  
Piercey MF, 1996, NEUROSCI LETT, V219, P138, DOI 10.1016/S0304-3940(96)13182-7
[46]   ANTIPSYCHOTIC MEDICATION, D2-DOPAMINE RECEPTOR BLOCKADE AND CLINICAL-RESPONSE - A I-123 IBZM SPET (SINGLE-PHOTON EMISSION TOMOGRAPHY) STUDY [J].
PILOWSKY, LS ;
COSTA, DC ;
ELL, PJ ;
MURRAY, RM ;
VERHOEFF, NPLG ;
KERWIN, RW .
PSYCHOLOGICAL MEDICINE, 1993, 23 (03) :791-797
[47]  
RABINER E, 2007, SOC NUCL MED ANN M B, V48, pP113
[48]  
RABINER E, 2008, SOC BIOL PSYCH ANN M
[49]  
RABINER E, 2007, ACNP 46 ANN M BOC RA
[50]   Mechanisms of inverse agonist action at D2 dopamine receptors [J].
Roberts, DJ ;
Strange, PG .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (01) :34-42